I & @JackScannell13 wrote a manifesto on reviving pharma productivity for @IFP. Public debates focus on improving science or loosening approval. We argue there's real leverage in optimizing the middle part of the drug discovery funnel: Clinical Trials.

From Twitter
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments